日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sparstolonin B potentiates the antitumor activity of nanovesicle-loaded drugs by suppressing the phagocytosis of macrophages in vivo

Sparstolonin B 通过抑制体内巨噬细胞的吞噬作用,增强纳米囊泡载药的抗肿瘤活性。

Zhang, Yuefeng; Mou, Zuo; Song, Wei; He, Xiaoqin; Yi, Qin; Wang, Zhekai; Mao, Xietong; Wang, Wei; Xu, Yangtao; Shen, Yang; Ma, Peng; Yu, Kaihuan

Extreme hepatectomy with modified ALPPS in a rat model: gradual portal vein restriction associated with hepatic artery restriction

在改良ALPPS的大鼠模型中进行极度肝切除术:门静脉逐渐受限,并伴有肝动脉受限

He, Xiaoqin; Zhang, Yuefeng; Ma, Peng; Mou, Zuo; Wang, Wei; Yu, Kaihuan; Wang, Weixing

Protein succinylation associated with the progress of hepatocellular carcinoma.

蛋白质琥珀酰化与肝细胞癌的进展相关

Bai Wenhui, Cheng Li, Xiong Liangkun, Wang Maoming, Liu Hao, Yu Kaihuan, Wang Weixing

Identification of Prognostic Genes in Hepatocellular Carcinoma

肝细胞癌预后基因的鉴定

Bai, Wenhui; Cheng, Li; Xiong, Liangkun; Wang, Maoming; Liu, Hao; Yu, Kaihuan; Wang, Weixing

Predictors of mortality for hospitalized young adults aged less than 60 years old with severe COVID-19: a retrospective study

预测60岁以下重症COVID-19住院青年患者死亡率的因素:一项回顾性研究

Liu, Zilong; Liu, Jie; Ye, Ling; Yu, Kaihuan; Luo, Zhe; Liang, Chao; Cao, Jiangtian; Wu, Xu; Li, Shanqun; Zhu, Lei; Xiang, Guiling

Low CD4 T cell count predicts radiological progression in severe and critically ill COVID-19 patients: a case control study

CD4 T 细胞计数低可预测重症和危重症 COVID-19 患者的放射学进展:一项病例对照研究

Wang, Qingqing; Yao, Yumeng; Huang, Zheyong; Cao, Jiatian; Zhu, Chouwen; Yu, Kaihuan; Pan, Jue; Hu, Bijie

Myocardial injury and COVID-19: Serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease

心肌损伤与 COVID-19:血清高敏肌钙蛋白I (hs-cTnI) 水平在 COVID-19 患者风险分层及 30 天死亡率预测中的应用(既往无心血管疾病史)

Cao, Jiatian; Zheng, Yan; Luo, Zhe; Mei, Zhendong; Yao, Yumeng; Liu, Zilong; Liang, Chao; Yang, Hongbo; Song, Yanan; Yu, Kaihuan; Gao, Yan; Zhu, Chouwen; Huang, Zheyong; Qian, Juying; Ge, Junbo

D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study

D-二聚体作为COVID-19患者疾病严重程度和死亡率的生物标志物:一项病例对照研究

Yao, Yumeng; Cao, Jiatian; Wang, Qingqing; Shi, Qingfeng; Liu, Kai; Luo, Zhe; Chen, Xiang; Chen, Sisi; Yu, Kaihuan; Huang, Zheyong; Hu, Bijie

The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension

RAS阻滞剂对合并高血压的COVID-19患者临床特征的影响

Huang, Zheyong; Cao, Jiatian; Yao, Yumeng; Jin, Xuejuan; Luo, Zhe; Xue, Yuan; Zhu, Chouwen; Song, Yanan; Wang, Ying; Zou, Yunzeng; Qian, Juying; Yu, Kaihuan; Gong, Hui; Ge, Junbo

Erratum to the effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension

关于 RAS 阻滞剂对合并高血压的 COVID-19 患者临床特征影响的勘误

Huang, Zheyong; Cao, Jiatian; Yao, Yumeng; Jin, Xuejuan; Luo, Zhe; Xue, Yuan; Zhu, Chouwen; Song, Yanan; Wang, Ying; Zou, Yunzeng; Qian, Juying; Yu, Kaihuan; Gong, Hui; Ge, Junbo